Evidence map›Paper›PMID 24909977›Full record

ArticleNature communications2014

A histone H3K36 chromatin switch coordinates DNA double-strand break repair pathway choice.

Chen-Chun Pai, Rachel S Deegan, Lakxmi Subramanian, Csenge Gal, Sovan Sarkar, Elizabeth J Blaikley, Carol Walker, Lydia Hulme, Eric Bernhard, Sandra Codlin and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 164 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. HumanResearch square · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Acetylation of Histone H3 in Cancer Progression and Prognosis.International journal of molecular sciences · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Chen-Chun Pai *CRUK MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, UK.
Rachel S Deegan *CRUK MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, UK.
Lakxmi SubramanianWellcome Trust Centre for Cell Biology, Institute of Cell Biology, The University of Edinburgh, Swann Building, Mayfield Road, Edinburgh EH9 3JR, UK.
Csenge GalInstitute for Cell and Molecular Biosciences, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.
Sovan SarkarCRUK MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, UK.
Elizabeth J BlaikleyCRUK MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, UK.
Carol WalkerCRUK MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, UK.
Lydia HulmeCRUK MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, UK.
Eric BernhardCRUK MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, UK.
Sandra CodlinUniversity College London, Department of Genetics, Evolution and Environment, Darwin Building, Gower Street, London WC1E 6BT, UK.
Jürg BählerUniversity College London, Department of Genetics, Evolution and Environment, Darwin Building, Gower Street, London WC1E 6BT, UK.
Robin AllshireWellcome Trust Centre for Cell Biology, Institute of Cell Biology, The University of Edinburgh, Swann Building, Mayfield Road, Edinburgh EH9 3JR, UK.
Simon WhitehallInstitute for Cell and Molecular Biosciences, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.
Timothy C HumphreyCRUK MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, ORCRB, Roosevelt Drive, Oxford OX3 7DQ, UK.
CRUK/MRC Oxford Institute for Radiation Oncology · GBUniversity of Oxford · GBNewcastle University · GB

Funding

Medical Research Council MC_PC_12003Medical Research Council R06538Medical Research Council R19583Wellcome Trust 065061Wellcome Trust 092076Wellcome Trust 095021Wellcome Trust 095598Wellcome Trust 095598/Z/11/Z
6 · The paper itself

Abstract

DNA double-strand break (DSB) repair is a highly regulated process performed predominantly by non-homologous end joining (NHEJ) or homologous recombination (HR) pathways. How these pathways are coordinated in the context of chromatin is unclear. Here we uncover a role for histone H3K36 modification in regulating DSB repair pathway choice in fission yeast. We find Set2-dependent H3K36 methylation reduces chromatin accessibility, reduces resection and promotes NHEJ, while antagonistic Gcn5-dependent H3K36 acetylation increases chromatin accessibility, increases resection and promotes HR. Accordingly, loss of Set2 increases H3K36Ac, chromatin accessibility and resection, while Gcn5 loss results in the opposite phenotypes following DSB induction. Further, H3K36 modification is cell cycle regulated with Set2-dependent H3K36 methylation peaking in G1 when NHEJ occurs, while Gcn5-dependent H3K36 acetylation peaks in S/G2 when HR prevails. These findings support an H3K36 chromatin switch in regulating DSB repair pathway choice.

Indexed as

DNA End-Joining RepairDNA RepairRecombinational DNA RepairAcetylationAcetyltransferasesChromatinDNA, FungalHistone-Lysine N-MethyltransferaseHistonesMethylationp300-CBP-Associated FactorSchizosaccharomycesSchizosaccharomyces pombe ProteinsAcetyltransferasesChromatinDNA, FungalGcn5 protein, S pombeHistone-Lysine N-MethyltransferaseHistonesp300-CBP-Associated FactorSchizosaccharomyces pombe ProteinsSet2 protein, S pombe

Identifiers

PMID24909977
PMCPMC4535359
OpenAlexW2032657745

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.